February 25, 2022
Sobi’s HLH Drug Recommended for Approval in China
Sobi has announce that the Center for Drug Evaluation (CDE) has recommended approval of Gamifant to the National Medical Products…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
February 25, 2022
Valneva Receives Initial CHMP Assessment of its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, has announced that the Committee for Medicinal Products for…
February 25, 2022
Idorsia’s QUVIVIQ (daridorexant) Recommended for Approval in Europe as a New Treatment for Adults with Insomnia Disorder
Idorsia Ltd has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European…
February 24, 2022
Atamyo Therapeutics Reaches Significant Regulatory and Financial Milestones for ATA-100, its Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2I/R9
Additional approval of Clinical Trial Application received from Denmark Danish Medicines Agency (DKMA) Orphan Drug Designation awarded from US FDA…
February 24, 2022
Orphazyme announces update on regulatory review of arimoclomol in the European Union
Orphazyme A/SCompany announcementNo. 07/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 23, 2022 – Orphazyme A/S (ORPHA.CO (DK); ORPH (US))…
February 22, 2022
dievini quits selling CureVac’s common shares to the public
dievini Hopp BioTech holding GmbH & Co. KG (dievini), DH-LT-Investments GmbH and Dietmar Hopp, as well as the managing directors…
February 22, 2022
TargED raises Series A financing of EUR 39 million to accelerate development of its lead compound
TargED Biopharmaceuticals (“TargED”), a private biotechnology company focused on developing improved treatments for thrombotic diseases, has announced it has raised…
February 22, 2022
Myricx Pharma announces senior team expansion with appointment of CMO, and Heads of Biology and Bioinformatics
Myricx Pharma (‘Myricx’), a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT)…
February 22, 2022
BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
Collaboration leverages BioNTech’s multi-platform immunotherapy capabilities and Medigene’s T cell receptor (TCR) discovery platform to discover and develop innovative TCR…
February 21, 2022
Molecule partners to develop Web3-based ecosystem addressing inefficiencies in biopharma R&D
Molecule, a biotech IP Web3 marketplace, has announced a tripartite partnership with Apollo Health Ventures, a longevity-focused venture capital fund,…